oral glp-1 medications FDA approves Foundayo, an alternative to Wegovy and Ozempic What employers need to know
Description
[5] PR Newswire

The valuation is expected to reach USD 65.84 Billion by 2031

Broader Applications of GLP-1 Medications GLP-1 medications arent just about weight management they also contribute to better cardiovascular health

In diabetes, the emphasis may be on glycemic monitoring and integration with other medications

GLP-1 medications are not immunosuppressants and don't share metabolic pathways with biologics

Work with a GP, registered dietitian, or qualified medical weight management provider who can create a plan tailored to your needs and health history
